1-20 of 33
Anna Turkina
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase-3 study of vamotinib (PF-114) versus high-dose imatinib

Free
Anna Turkina, Olga Vinogradova, Nuriya Kalimulina, Tatyana Shelekhova, Igor Davydkin, Bulat Bakirov, Tatiana Pospelova, Elza Lomaia, Jitendra Pehalajani, Vishvdeep Khushoo, Shashikant Apte, Robert Gale, Ghermes Chilov
Journal: Blood
Blood (2025) 146 (Supplement 1): 7290.
https://doi.org/10.1182/blood-2025-7290
Published: 2025
Journal Articles

Somatic mutations in cancer-related genes in chronic myeloid leukemia patients receiving asciminib

Free
Elena Kuzmina, Ekaterina Chelysheva, Bella Biderman, Oleg Shukhov, Anna Petrova, Elena Stepanova, Irina Nemchenko, Anastasiya Bykova, Margarita Gurianova, Alina Kokhno, Andrey Sudarikov, Anna Turkina
Journal: Blood
Blood (2025) 146 (Supplement 1): 2000.
https://doi.org/10.1182/blood-2025-2000
Published: 2025
Journal Articles

Asciminib and pregnancy in CML: Preliminary human data and clinical implications from 47 reported outcomes

Free
Elisabetta Abruzzese, Ekaterina Chelysheva, Delphine Rea, Katia Pagnano, Mohamed Yassin, Nithya Agrawal, Malgorzata Trawinska, Anna Turkina, Jane Apperley, Paolo De Fabritiis
Journal: Blood
Blood (2025) 146 (Supplement 1): 5566.
https://doi.org/10.1182/blood-2025-5566
Published: 2025
Journal Articles

Olverembatinib (HQP1351) Overcomes Resistance/Intolerance to Asciminib and Ponatinib in Patients (pts) with Heavily Pretreated Chronic-Phase Chronic Myeloid Leukemia (CP-CML): A 1.5-Year Follow-up Update with Comprehensive Exposure-Response (E-R) Analyses

Free
Elias Jabbour, Omer Jamy, Paul B. Koller, Vivian G. Oehler, Maria R. Baer, Elza Lomaia, Anthony M. Hunter, Olga Uspenskaya, Svetlana Samarina, Jorge E. Cortes, Sudipto Mukherjee, Dennis Dong Hwan Kim, Vera Zherebtsova, Vasily Shuvaev, Anna Turkina, Igor Davydkin, Huanshan Guo, Zi Chen, Hengbang Wang, Tommy Fu, Lixin Jiang, Zhihong Yang, Cunlin Wang, Dajun Yang, Yifan Zhai, Hagop Kantarjian
Journal: Blood
Blood (2024) 144 (Supplement 1): 3151.
https://doi.org/10.1182/blood-2024-207139
Published: 2024
Journal Articles

Results of the Molecular Response Evaluation and TKI Dose Adjustment in Chronic Myeloid Leukemia Patients in Prospective Study of Reduction and Discontinuation Treatment of TKI (READIT)

Free
Oleg Shukhov, Margarita Gurianova, Ekaterina Chelysheva, Anna Petrova, Anastasiya Bykova, Irina Nemchenko, Andrey Sudarikov, Elena Kuzmina, Lyubov Gavrilova, Alina Kokhno, Anna Turkina
Journal: Blood
Blood (2024) 144 (Supplement 1): 4539.
https://doi.org/10.1182/blood-2024-199962
Published: 2024
Journal Articles

The Updated Results of Asciminib Managed-Access Program (MAP) in Patients with Chronic Myeloid Leukemia in Russia

Free
Elena Kuzmina, Ekaterina Chelysheva, Elza Lomaia, Elena V Morozova, Oleg Shukhov, Anna Petrova, Tamara Chitanava, Julia Vlasova, Evgenia Sbitiakova, Natalia Lazorko, Irina Nemchenko, Anastasiya Vitalievna Bykova, Margarita Gurianova, Alina Kokhno, Anna Turkina
Journal: Blood
Blood (2023) 142 (Supplement 1): 1803.
https://doi.org/10.1182/blood-2023-181789
Published: 2023
Journal Articles

Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL)

Free
Elias Jabbour, Hagop M. Kantarjian, Paul B. Koller, Omer Jamy, Vivian G. Oehler, Elza Lomaia, Anthony M. Hunter, Olga Uspenskaya, Svetlana Samarina, Sudipto Mukherjee, Maria R. Baer, Vera Zherebtsova, Vasily Shuvaev, Anna Turkina, Igor Davydkin, Jorge Cortes, Huanshan Guo, Zi Chen, Lei Fu, Hengbang Wang, Lixin Jiang, Cunlin Wang, Dajun Yang, Yifan Zhai
Journal: Blood
Blood (2023) 142 (Supplement 1): 1798.
https://doi.org/10.1182/blood-2023-187744
Published: 2023
Journal Articles

Asciminib (ASC) Add-on to Imatinib (IMA) Demonstrates Sustained High Rates of Ongoing Therapy and Deep Molecular Responses (DMRs) with Prolonged Follow-up in the ASC4MORE Study

Free
Timothy P Hughes, Giuseppe Saglio, Jan Geissler, Dong-Wook Kim, Elza Lomaia, Jiri Mayer, Anna Turkina, Shruti Kapoor, Ana Paula Torres Cardoso, Jomy Jose, Monali Sura, Jorge Cortes
Journal: Blood
Blood (2023) 142 (Supplement 1): 866.
https://doi.org/10.1182/blood-2023-182100
Published: 2023
Journal Articles

Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Follow-up from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): An End of Study Treatment (EOS Tx) Update, Including Results from Switch Population

Free
Michael Mauro, Yosuke Minami, Andreas Hochhaus, Elza Lomaia, Sergei Voloshin, Anna Turkina, Dong-Wook Kim, Jane F Apperley, Jorge Cortes, Andre N.R. Abdo, Laura Maria Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saussele, Mario Annunziata, Timothy P Hughes, Naeem A. Chaudhri, Lynette C.Y. Chee, Valentín García Gutiérrez, Koji Sasaki, Carla Maria Boquimpani De Moura Freitas, Shruti Kapoor, Noemi Espurz, Vishal Dhamal, Delphine Rea
Journal: Blood
Blood (2023) 142 (Supplement 1): 4536.
https://doi.org/10.1182/blood-2023-186854
Published: 2023
Journal Articles

Long-Term Results from the Optic Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib

Free
Jorge Cortes, Michael Deininger, Elza Lomaia, Beatriz Moiraghi, Soledad Undurraga, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Lori Maness, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane F Apperley
Journal: Blood
Blood (2023) 142 (Supplement 1): 3164.
https://doi.org/10.1182/blood-2023-178790
Published: 2023
Journal Articles

Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia

Free
Anna Turkina, Elena A. Kuzmina, Elza Lomaia, Elena Morozova, Oleg A. Shukhov, Anna N. Petrova, Tamara Chitanava, Julia J. Vlasova, Ekaterina Yu. Chelysheva, Evgeniya Sbityakova, Irina S. Nemchenko, Anastasiya V. Bykova, Margarita A. Gurianova, Alina V. Kokhno, Elena N. Parovichnikova
Journal: Blood
Blood (2022) 140 (Supplement 1): 9654–9655.
https://doi.org/10.1182/blood-2022-162268
Published: 2022
Journal Articles

Chronic Myeloid Leukemia Diagnosed during Pregnancy: How to Manage? Description of 86 Cases from ELN International Registry

Free
Ekaterina Yu. Chelysheva, Anna Turkina, Jane F. Apperley, Mohamed A Yassin, Delphine Rea, Franck E. Nicolini, Daniela Barraco, Konstantin Kotlyarchuk, Khamida Kazakbaeva, Sukhrob Saliev, Adi Shacham, Dong-Wook Kim, Salam Al-Kindi, Penka Ganeva, Roman Shmakov, Jennifer Byrne, Harry Robertson, Cerrano Marco, Evgenia Polushkina, Malgorzata Monika Trawinska, Elisabetta Abruzzese
Journal: Blood
Blood (2022) 140 (Supplement 1): 1498–1500.
https://doi.org/10.1182/blood-2022-159993
Published: 2022
Journal Articles

Three-Year Update from the Optic Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib

Free
Jorge E. Cortes, Michael W. Deininger, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Christine Rojas, Anna Turkina, Lori Maness, Moshe Talpaz, Michael Mauro, Vickie Lu, Alexander Vorog, Jane F. Apperley
Journal: Blood
Blood (2022) 140 (Supplement 1): 1495–1497.
https://doi.org/10.1182/blood-2022-157822
Published: 2022
Journal Articles

ASC4OPT: A Phase 3b Open-Label Optimization Study of Oral Asciminib in Chronic Myelogenous Leukemia in Chronic Phase Previously Treated with 2 or More Tyrosine Kinase Inhibitors

Free
Massimo Breccia, Anna Turkina, Carla Boquimpani, Charles Chuah, Giora Sharf, Luigi Di Caprio, Matthias Hoch, Justin Yssel, Yifan Zhang, Andreas Hochhaus
Journal: Blood
Blood (2022) 140 (Supplement 1): 9635–9636.
https://doi.org/10.1182/blood-2022-157991
Published: 2022
Journal Articles

Molecular Response of ≤10% BCR::ABL1 IS Is Predictive of Positive Outcomes in Treatment-Resistant Patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML) Treated with Ponatinib from the Phase 2 Optic Trial

Free
Jane F. Apperley, Jorge E. Cortes, Elias Jabbour, Andreas Hochhaus, Timothy Hughes, Charles Chuah, Hugues de Lavallade, Michael W. Deininger, Jeffrey H. Lipton, Elza Lomaia, Lori Maness, Michael Mauro, James McCloskey, Beatriz Moiraghi, Carolina Pavlovsky, Christine Rojas, Philippe Rousselot, Tomasz Sacha, Moshe Talpaz, Anna Turkina, Maria Undurraga Sutton, Xiaowei Ren, Alexander Vorog, Gianantonio Rosti
Journal: Blood
Blood (2022) 140 (Supplement 1): 6760–6762.
https://doi.org/10.1182/blood-2022-157956
Published: 2022
Journal Articles

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

Free
Clinical Trials & Observations
Delphine Réa, Michael J. Mauro, Carla Boquimpani, Yosuke Minami, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Jane F. Apperley, Andre Abdo, Laura Maria Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saussele, Mario Annunziata, Timothy P. Hughes, Naeem Chaudhri, Koji Sasaki, Lynette Chee, Valentin García-Gutiérrez, Jorge E. Cortes, Paola Aimone, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Andreas Hochhaus
Journal: Blood
Blood (2021) 138 (21): 2031–2041.
https://doi.org/10.1182/blood.2020009984
Published: 2021
Includes: Supplemental data
Journal Articles

Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial

Free
Clinical Trials & Observations
Jorge Cortes, Jane Apperley, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, Charles A. Schiffer, James McCloskey, Andreas Hochhaus, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Anna Turkina, Christine Rojas, Christopher Kevin Arthur, Lori Maness, Moshe Talpaz, Michael Mauro, Tracey Hall, Vickie Lu, Shouryadeep Srivastava, Michael Deininger
Journal: Blood
Blood (2021) 138 (21): 2042–2050.
https://doi.org/10.1182/blood.2021012082
Published: 2021
Includes: Supplemental data
Journal Articles

Alterations in the Physiology of Multipotent Mesenchymal Stromal Cells from the Bone Marrow of Patients with Leukemia

Free
Tamara Sorokina, MD, Irina Shipounova, PhD, Alexey Bigildeev, PhD, Nataliya Petinati, PhD, Nina I. Drize, PhD, Anna Turkina, Prof., MD, Ekaterina Chelysheva, MD PhD, Oleg Shukhov, MD, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G Savchenko, PhD MD
Journal: Blood
Blood (2015) 126 (23): 4768.
https://doi.org/10.1182/blood.V126.23.4768.4768
Published: 2015
Journal Articles

The Rate of Individual BCR-ABL Decline As an Optimized Predictor of Tyrosine Kinase Inhibitors Treatment Outcome in Chronic Phase CML Patients, Comparison with CML Prognostic Scores and Early Molecular Response Achievement

Free
Mikhail Fominykh, MD, Vasily Shuvaev, MD, Irina Martynkevich, MD PhD, Grigory Tsaur, MDPhD, Natalya Bederak, Ekaterina Chelysheva, Oleg Shukhov, MD, Adhamjon Abdullaev, MD PhD, Vera Udaleva, MD, Regina Golovchenko, MD, Irina Zotova, Dzhariyat Shikhbabaeva, Lyubov Polushkina, Ekaterina Petrova, Marina Ivanova, Lyudmila Martynenko, Elizaveta Kleina, Natalya Cybakova, Anna Turkina, Prof., MD, Kudrat Abdulkadyrov, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5150.
https://doi.org/10.1182/blood.V126.23.5150.5150
Published: 2015
Journal Articles

Russian Registry of Chronic Myeloid Leukemia Management in Routine Clinical Practice-Local Therapy and Monitoring

Free
Anna Turkina, Prof., MD, Anatoly Golenkov, MD, Lyudmila Napso, Irina Krylova, Tatiana Klitochenko, Olga Senderova
Journal: Blood
Blood (2015) 126 (23): 5156.
https://doi.org/10.1182/blood.V126.23.5156.5156
Published: 2015